AUS
NZ
UK
CA
USA
IND
_06_04_2026_05_16_02_212823.jpg)
Highlights
ASX 200 small-cap companies reported notable updates, with developments across healthcare technology, mineral exploration, and rare earths. While broader market indices moved in different directions, sector activity reflected ongoing project milestones and corporate advancements.
Orthocell expands US rollout for Remplir
Orthocell (ASX:OCC) has continued its progress in introducing the Remplir nerve repair device to the United States market. Early use of the product has been completed across select medical facilities, building on experience gained in Australia and Singapore.
The company has submitted multiple hospital Value Assessment Committee applications and has already secured approvals from several institutions. Shipments from its Western Australia facility have been directed to its logistics partner in the United States, supporting a growing distribution footprint.
Orthocell has expanded its dedicated sales team and confirmed distributor arrangements covering numerous US states, aiming to enhance accessibility for healthcare providers and medical specialists.
Antipa Minerals adds leadership expertise
Antipa Minerals (ASX:AZY) has announced the appointment of a seasoned mining professional to its board as a non-executive director. The appointee brings extensive operational and corporate leadership experience from across the Australian resources sector.
This addition comes as Antipa advances work on its Minyari Dome Gold-Copper Development Project, which is fully owned by the company. The project aims to progress towards production, supported by ongoing exploration programs designed to enhance the project’s resource base.
The newly appointed board member also holds chair roles with other listed entities and has previously served on the board of major mining companies following significant industry transactions.
European Lithium progresses Tanbreez DFS
European Lithium (ASX:EUR) has confirmed that Tanbreez Mining Greenland A/S has selected engineering and environmental consultancy NIRAS A/S to complete the Definitive Feasibility Study for the Tanbreez Rare Earth Project.
The study will address aspects such as mine planning, processing plant engineering, logistics, environmental considerations, and integration of social impact measures. Updated financial modelling will also be included as part of the assessment.
Completion of the study is expected to support the project’s exploitation licence application and move the development closer to receiving approval for commercial operations. European Lithium holds a minority stake in Tanbreez through its interest in a NASDAQ-listed entity.
Frequently Asked Questions
- What is Orthocell known for?
It is known for developing regenerative medicine products such as the Remplir nerve repair device. - What project is Antipa Minerals advancing?
It is advancing the Minyari Dome Gold-Copper Development Project. - Where is the Tanbreez Rare Earth Project located?
It is located in southern Greenland.
